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Abstract
Background: Under-dimensioned hearts causing functional problems are associated with higher mortality rates in
intensive Atlantic salmon aquaculture. Previous studies have indicated that tetradecylthioacetic acid (TTA) induces
cardiac growth and also stimulates transcription of peroxisome proliferator activated receptors (PPAR) α and β in the
Atlantic salmon heart. Since cardiac and transcriptional responses to feed are of high interest in aquaculture, the
objective of this study was to characterize the transcriptional mechanisms induced by TTA in the heart of Atlantic
salmon.
Results: Atlantic salmon were kept at sea for 17 weeks. During the ﬁrst 8 weeks the ﬁsh received a TTA supplemented
diet. Using microarrays, profound transcriptional eﬀects were observed in the heart at the end of the experiment, 9
weeks after the feeding of TTA stopped. Approximately 90% of the signiﬁcant genes were expressed higher in the TTA
group. Hypergeometric testing revealed the over-representation of 35 gene ontology terms in the TTA fed group. The
GO terms were generally categorized into cardiac performance, lipid catabolism, glycolysis and TCA cycle.
Conclusions: Our results indicate that TTA has profound eﬀects on cardiac performance based on results from
microarray and qRT-PCR analysis. The gene expression proﬁle favors a scenario of ”physiological”lright hypertrophy
recognized by increased oxidative fatty acid metabolism, glycolysis and TCA cycle activity as well as cardiac growth
and contractility in the heart ventricle. Increased cardiac eﬃciency may oﬀer signiﬁcant beneﬁts in the demanding
Aquaculture situations.
Background
High levels of dietary lipids are used in commercial
Atlantic salmon diets to promote rapid growth and as
a inexpensive source of energy. These high lipid levels
may promote excess lipid deposition in the viscera and
the muscle, thereby reducing the market quality of the
ﬁsh. Thus, tetradecylthioacetic acid (TTA: CH3-(CH2)13-
S−CH2-COOH) has been tested for aquaculture nutri-
tion, initially to increase lipid catabolism and thereby
reducing lipid deposition [1]. However, beneﬁcial eﬀects
on cardiac growth and disease resistance have also been
addressed.
TTA is a modiﬁed fatty acid (FA) that possesses a
sulfur atom in the β position. Like a normal FA, TTA
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can be converted to co-enzyme A thioester, but further
catabolism by β-oxidation does not occur. This lack of
metabolism is likely to determine the biological eﬀects
of TTA. Biological eﬀects of TTA have been the focus
of extensive research in rodents and also in humans.
The most important ﬁndings from these experiments are
that TTA increases the mitochondrial and peroxisomal
β-oxidation and possesses hypolipidemic eﬀects. In addi-
tion, TTA acts as an antioxidant in vivo and can modulate
the inﬂammatory response (reviewed in [2]). Cell cul-
ture experiments demonstrated that TTA can act as a
ligand for all Peroxisome proliferator activated receptors
(PPARs) [3,4], which are ligand-activated transcription
factors. Upon ligand activation PPARs heterodimerizes
with retinoic-x-acid receptor (RXR) and have been shown
to regulate the expression of genes involved in fatty acid
© 2012 Grammes et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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metabolism, cell diﬀerentiation, development and inﬂam-
mation (reviewed in [5]). Arguably most of the biological
eﬀects of TTA are mediated through activation of PPARs.
Studies addressing the biological eﬀects of TTA in
Atlantic salmon have demonstrated that TTA increases
β-oxidation in the liver [1] and white muscle [6]. Fur-
thermore, TTA reduces the secretion of triacylglycerides
from Atlantic salmon hepatocytes in vitro [7] and has
been shown to increase the expression of genes asso-
ciated with fat metabolism in the liver and the heart
ventricle [1,8]. Previous results also suggested that TTA
stimulates the transcription of PPARα and β in the heart
[8,9], thus indicating that TTA aﬀects the metabolism in
Atlantic salmon through activation of PPARs, similar to
the mechanism known from rodents. Interestingly, this
activation of PPARs may have been related to increased
survival after a natural outbreak of a heart related viral
disease in Atlantic salmon [8,9]. In mammals, cardiac
activation of PPARs has yielded substantial attention due
to the fact that PPARs have been proven to be major
regulators of cardiac metabolism [10-13]. In addition,
PPAR agonists have been reported to exert beneﬁcial
eﬀects by attenuating the pathogenesis of heart failure and
atherosclerosis [14,15].
Poor development of the outer muscle layer, atheroscle-
rosis and metabolic dysfunction have been related to
under-dimensioned hearts and reduced cardiac function
in Atlantic salmon aquaculture, consequently resulting in
increased mortality [16]. Therefore, methods to improve
cardiac metabolism and performance in ﬁsh are needed;
something which has been sparsely studied. It appears
that, similar to themammalian heart, the oxidative cardiac
metabolism in ﬁsh depends on the metabolism of fatty
acids and glucose [17].
This study aims to characterize the cardiac transcrip-
tional response of Atlantic salmon to a TTA supplemented
diet. A feeding trial was conducted in sea, feeding a
control and TTA supplemented diet during the ﬁrst 8
weeks and only control diet for the subsequent 9 weeks of
the experiment. Fish were sampled both at the end of the
TTA feeding period (8.weeks) and at the end of the exper-
iment (17.weeks). Our results show that administration of
TTA to Atlantic salmon resulted in a marked change of
cardiac gene expression. The expression proﬁle suggests
that TTA induces cardiac fatty acid oxidation, glycolysis,
TCA cycle and contractility as well as cardiac growth.
Results
Production data
Atlantic salmon that were fed with 0.25% TTA had sig-
niﬁcantly lower fat content in the muscle at the 8.weeks
sampling point, and showed a tendency for increased
mean relative heart weight (Table 1). No signiﬁcant eﬀect
of TTA on ﬁsh weight was detected. During the experi-
ment none of the dietary groups showed higher mortality
than the control group. In the heart ventricles, 120.2
μgTTA/gTissue was detected at the 8.weeks sampling
point in the TTA group, while 1.2 μgTTA/gTissue was
detected in the control group. Based on the TTA mea-
surements of a group fed a higher (0.5% w/w) TTA diet
from the same trial, we can assume that the TTA levels in
the heart ventricles at the 17.weeks sampling point were
no diﬀerent to the control group (see Additional ﬁle 1:
Table S1).
Microarray analysis
RNA cardiac samples from six individual ﬁsh from each
dietary group and sampling point were used in the
microarray analysis, utilizing the Atlantic salmon SIQ2
microarray [18] in a one-color setup, resulting in a total
of 24 arrays. After normalization and ﬁltering, 13166
probes (63%) were classiﬁed as present. To obtain a global
overview of the general structure of the dataset we applied
correspondence analysis (CA) as an explorative technique
Table 1 Eﬀect of TTA on Atlantic salmon production parameters
Start sampling 8.weeks 17.weeks
Control 0.25% TTA Control 0.25% TTA
Weight[g] 102± 5 166±1 165±1 438±4 440±2
CF1 1.2 ± 0.1 1.1±0.1 1.1± 0.1 1.2± 0.1 1.2± 0.1
LI2 0.82±0.05 1.00±0.02 1.07±0.07 1.43±0.04 1.41± 0.04
CSI3 0.074±0.002 0.092±0.001 0.094±0.001 0.101±0.002 0.103± 0.002
Mortality[%] 0.74± 0.18 0.41± 0.27 2 ± 0.23 2 ± 0.21
Muscle fat content4[%] 4.2a±0.1 3.9b±0.1 6.5±0.4 6.8±0.1
Values within the same row with diﬀerent subscripts are signiﬁcantly diﬀerent (p ≤ 0.05, t-test). Mean ± SEM, the statistical unit is the mean of the net pen (n = 3). 19
ﬁsh were used to calculate the net pen mean.
1Condition factor (CF) = 1000×weight[g]length[g]3 .
2Liver index (LI) = liver−weight[g]weight[g] × 100.
3Cardio somatic index (CSI) = heart−weight[g]weight[g] × 100.
4Muscle samples (NQC: Norwegian quality cut) from 10 ﬁsh/cage were pooled to analyse the muscle fat content.
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[19]. The ﬁrst 2 components of the CA are displayed,
together explaining 67% of the total inertia of the diﬀerent
samples (Figure 1). The analysis shows a clear distinction
between the two sampling points at 8.weeks and 17.weeks.
It further shows a relatively dense cluster at the 8.weeks
point with minor separation between samples from the
TTA and control group. Even though it was impossible to
draw a straight line to separate between the TTA and con-
trol samples at the 17.weeks sampling point, we observed
a clear tendency of separation.
To identify diﬀerentially expressed (DE) probes in the
data set we used moderated t-statistics [20], comparing
samples from TTA to control fed Atlantic salmon for each
sampling point.
Sampling point: 8.weeks, end of TTA feeding
At the 8.weeks sampling point, ﬁve genes were found to be
DE between the TTA and the control fed group (Figure 2).
The genes were: Ephrin-b2, arf gtpase-activating pro-
tein (git2), f-box only protein 11 (fbx11), angiopoietin-
related protein 4 (ANGPTL4) and sodium- and chloride-
dependent creatine transporter 1 (sc6a8). Ephrin-b2 was
the only gene found to be down-regulated in the TTA fed
group.
Ephrin-b2 (Efnb2) in mammals has been reported to be
highly expressed in the heart and serves also as a marker
for angiogenesis [21]. The protein GIT-2 participates in
pleiotropic cellular processes like cell migration and T-
cell activation; however, a function aﬀecting the structure
of the cytoskeleton [22] may be relevant in our study.
Cardiomyocytes rely solely on the creatine transporter
sc6a8 for the uptake of creatine from the plasma. Over-
expression of the creatinfabe transporter in mice has been
reported to correlate with the myocardial creatine con-
tent, but also to be associated with cardiac hypertrophy
[23]. Angiopoietin-related protein 4 possesses a role in
regulating angiogenesis and is also known as a target gene
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Figure 1 Correspondence Analysis (CA). CA of arrays from the two
dietary groups for both sampling points (8.weeks and 17.weeks), n = 6.
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Figure 2 Heatmaps of genes DE at 8.weeks. Columns display the
mean log2 signal of the biological replicates (n = 6), rows display the
genes (probe sets) showing DE. Rows were scaled and ordered by
hierarchical clustering using euclidean distances (indicated by the
dendrogram).
for PPARs and acts as an important stimulator of lipid
metabolism [24].
Sampling point: 17.weeks, 9 weeks post TTA feeding
1198 probes (930 genes) were found to be DE between
the TTA and the control fed group at the 17.weeks sam-
pling point. In order to facilitate a functional interpre-
tation of the vast number of DE genes, we tested them
for enrichment (over-representation) of GO terms from
the category “biological process” [25], using conditional
hypergeometric testing [26]. To ensure that one gene was
represented by a maximum of one probe [26], probes
matching the same gene were collapsed prior to hyper-
geometric testing. This step reduced the total number of
probes in the data set from 11143 to 7659 probes and
the number of DE probes from 1198 to 930 probes (930
genes). From these 930 genes, 90% showed higher gene
expression in the samples from TTA fed ﬁsh.
Conditional hypergeometric testing revealed signiﬁ-
cant over-representation of 36 GO terms. To simplify
interpretation, signiﬁcant GO terms were grouped into
ﬁve categories according to their function in the heart
(Table2). The grouping was further supported by a strong
gene overlap between the diﬀerent GO terms within the
categories (Additional ﬁle 2: Figure S1 and Additional
ﬁle 3: Table S2 ). Overall, the results from the enrichment
analysis suggests an increased capacity of heart ventricles
from TTA fed Atlantic salmon to catabolize lipids and
glycogen. Further, an increased capacity for cardiac con-
tractility and cardiac tissue morphogenesis is indicated.
Heart performance
The group fed TTA showed an up-regulation in the
expression of genes encoding contractile proteins like
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Table 2 Gene Ontology enrichment analysis for sampling point 17.weeks
GOID p-value Count1 Size2 Gene ontology term
Fat metabolism
GO:0046395 5.33e-04 24 96 carboxylic acid catabolic process
GO:0034440 5.69e-03 13 49 lipid oxidation
GO:0044242 8.41e-03 19 86 cellular lipid catabolic process
Heart performance
GO:0006936 1.56e-03 37 182 muscle contraction
GO:0008015 5.56e-03 38 202 blood circulation
GO:0003015 6.45e-03 22 102 heart process
GO:0008016 7.18e-03 17 73 regulation of heart contraction
GO:0055008 8.94e-03 12 46 cardiac muscle tissue morphogenesis
Citrate cycle (TCA)
GO:0009109 1.87e-07 15 28 co-enzyme catabolic process
GO:0006084 2.12e-07 18 39 acetyl-CoA metabolic process
GO:0006099 2.32e-07 14 25 tricarboxylic acid cycle
GO:0006091 9.39e-05 46 214 generation of precursor metabolites and energy
GO:0045333 3.49e-04 23 88 cellular respiration
GO:0044248 1.34e-03 36 180 cellular catabolic process
carbohydrate metabolism
GO:0006112 6.21e-04 16 54 energy reserve metabolic process
GO:0016052 1.17e-03 19 73 carbohydrate catabolic process
GO:0006073 1.27e-03 14 47 cellular glucan metabolic process
GO:0046164 1.77e-03 16 59 alcohol catabolic process
GO:0019320 2.97e-03 14 51 hexose catabolic process
GO:0006096 3.26e-03 12 41 glycolysis
Other
GO:0007338 1.27e-03 14 47 single fertilization
GO:0001824 1.59e-03 12 38 blastocyst development
GO:0051246 2.00e-03 86 514 regulation of protein metabolic process
GO:0010171 2.83e-03 20 84 body morphogenesis
GO:0055114 3.60e-03 40 210 oxidation reduction
GO:0007050 3.67e-03 19 80 cell cycle arrest
GO:0043009 5.00e-03 48 267 chordate embryonic development
GO:0001822 5.64e-03 19 83 kidney development
GO:0040010 6.35e-03 33 171 positive regulation of growth rate
GO:0009790 7.54e-03 124 815 embryo development
GO:0001655 8.41e-03 19 86 urogenital system development
GO:0070585 8.44e-03 10 35 protein localization in mitochondrion
GO:0044265 8.45e-03 66 399 cellular macromolecule catabolic process
GO:0007018 9.35e-03 16 69 microtubule-based movement
GO:0006839 9.35e-03 16 69 mitochondrial transport
GO:0006402 9.66e-03 13 52 mRNA catabolic process
1Number of times the GO term is represented in the list of DE genes, only GO terms having ≥ 10 genes were considered.
2Number of times the GO term is represented in the ﬁltered list of genes on the array.
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myosin heavy chain 6 (MYH6), myosin light chain
(MYL9), cardiac myosin binding protein (MYBPC3),
cardiac troponin (TNNT2), myomesin-1 (Myom1) and
actin (ACTA1, ACTA2).
Moreover, the same group showed increased expres-
sion of the cardiac homeodomain factor Nkx2.5 and the
iroquois-related homeobox factors 3 and 5 (irx3, irx5).
Nkx2.5 and the iroquois transcription factors have been
reported to control cardiac morphogenesis and growth
[27,28]. Furthermore, we observed increased expression
of FK506 binding protein 1A and 1B (FKBP1A, FKBP1B)
and Na+/K+-transporting ATPase subunit α3 (ATP2A2),
encoding an ion-pump responsible for establishing and
maintaining the electrochemical gradients at the plasma
membrane of the cardiomyocyte. Decreased amounts of
this transporter were found in biopsies from humans suf-
fering heart failure [29]. FKBP1A and B are known to
interact with intracellular calcium-release channels. In
cardiomyocytes FKBP1B is a binding partner for themajor
Ca2+ release channel ryanodine receptor 2 (RyR2). RyR2
is required for the Ca2+-induced Ca2+ release from the
sacroplasmatic reticulum (SR) causing activation of the
contractile proteins. Binding of FKBP1B to RyR2 results
in channel closure. Mice deﬁcient for FKBP1B showed
no divergence in the normal cardiac phenotype under
normal conditions but showed exercise-induced arrhyth-
mias [30]. In relation to Ca2+ signaling, we also found
the Na+/Ca2+ exchanger SLC8A1 to be up-regulated.
We also found an increased expression of the SR Ca2+
ATPase 2 (ATP2A2 also known as SERCA2), encoding an
SR calcium pump that is a key component of the cardiac
excitation-contraction mechanism [31].
TheKv channel interacting protein 1 (Kcnip1) was found
to be down-regulated. The protein Kcnip1 is an integral
part of the multimeric Kv4 channel complex, and impor-
tant for modulating the K-ﬂux across this channel by
causing a shortening of the cardiac action potential [32].
Prolongation of the cardiac action potential on the other
hand, potentially caused by decreased Kcnip1 expression,
is associated to cardiac hypertrophy [33].
In summary, the results suggest an increased car-
diac hypertrophy together with increased potential for
cardiac contractility, as indicated by the higher transcrip-
tion of the various ion channels/pumps and contractile
proteins.
Fat metabolism
Nearly all of the genes in this group were up-regulated
(Figure 3). We found up-regulation of the mitochondrial
trifunctional protein HADHA, the mitochondrial fatty
acid transporter carnitine palmitoyltransferase (Cpt1a),
lipoprotein lipase (Lpl), themitochondrial acyl-CoA dehy-
drogenases (ACADS, ACADV and ACADSB) and of per-
oxisomal multi-functional enzyme type 2 (Hsd17b4). We
also observed an up-regulation of malonyl-CoA decar-
boxylase (MLYCD). Malonyl-CoA is a potent inhibitor of
CPT1 and thus crucial in regulating the transport of fatty
acids into the mitochondria for catabolism. Malonyl-CoA
decarboxylase has been reported to function as a positive
regulator of cardiac fatty acid oxidation by decreasing the
levels of the CPT1 inhibitor malonyl-CoA [34]. Thus, the
results indicate increased fatty acid oxidation capacity in
cardiac ventricles from TTA fed Atlantic salmon.
Glycolysis
The genes of the six GO terms that were grouped
together contained almost entirely genes encoding
enzymes or subunits participating in glycolysis. We
found increased expression of hexokinase 1 (HXK1),
the phospho-fructokinases aldolase A (ALDOA) and 6-
phosphofructokinase type C (K6PP), glycerol-3-phosphate
dehydrogenase (GPDA/GAPDH) and the pyruvate dehy-
drogenases DLAT and OPDX. In accordance, we also
observed an increased expression ofMLX-interacting pro-
tein (MLXIP), which has been suggested to be an essen-
tial regulator of cellular glycolysis [35]. All of the genes
showed increased transcription, therefore clearly indi-
cating increased glycolysis in the hearts from TTA fed
Atlantic salmon.
Tricarboxylic acid (TCA) cycle
As in the previously described categories, almost all of
the genes in this category showed an increased expres-
sion. The proteins encoded by nearly all of the genes in
this category are part of the TCA-cycle. For a graphi-
cal representation of the genes within the TCA cycle, see
Additional ﬁle 4: Figure S2.
qRT-PCR
To validate themicroarray results, six genes were analyzed
by qRT-PCR between the TTA and control fed group for
the 8.weeks and 17.weeks samples, using the same RNA
samples that were used in the microarray experiment.
The results showed a signiﬁcant correlation between the
logFCs obtained by qRT-PCR and those obtained by
microarray (Pearson correlation r = 0.8314; p = 0.0008;
Figure 4).
In addition, we measured the gene expression of
the three PPAR subtypes α, β and γ in control and
TTA fed Atlantic salmon in the four diﬀerent tissues:
Heart, muscle, liver and gut (pyloric caeca) from both
sampling points (Figure 5A). Analyzing the expression
levels using analysis of variance (ANOVA) showed that
only the PPARα expression in the heart was signiﬁ-
cantly increased in the TTA group. The gene expres-
sion levels of PPARγ in heart and muscle were too
low to allow reliable quantiﬁcation. Since the microar-
ray data revealed quite clearly that TTA aﬀected genes
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Figure 3 Heatmaps of genes DE at 17.weeks. Unique genes from the diﬀerent categories (Table 2). Columns display the mean log2 signal of the
biological replicates (n = 6), rows display the genes (probe sets) showing DE. Rows were scaled and ordered by hierarchical clustering using
euclidean distances (indicated by the dendrogram).
are involved in regulating the heart performance, we
used qRT-PCR to measure the expression of the car-
diac transcription factors GATA4, Mef2C and osteonectin
(Osx). For all three transcription factors we observed a
trend of higher mean transcription in the TTA group
(Figure 5B), however, only Mef2C showed statistical
signiﬁcance.
TTA has previously been reported to stimulate mito-
chondrial biogenesis in mammals [36]. In this study TTA
had no eﬀect on mitochondrial biogenesis as measured by
the ratio of mt/nDNA (Figure 6). In the liver we found
a signiﬁcant interaction between dietary treatment and
time for mitochondrial biogenesis.
Discussion
In the present study we investigated the response of
Atlantic salmon to TTA during the seawater phase. The
results from our study show that feeding TTA had pro-
found eﬀects on the cardiac gene expression at sam-
pling point 17.weeks, 9 weeks after TTA feeding ended.
The level of TTA applied in the study was, with 0.25%,
lower than previous studies that have been conducted in
Atlantic salmon (compare [1,6,37]). The mortality rates
previously observed in Atlantic salmon in response to
high TTA levels was not observed in this study.
Gene set over-representation of the transcription proﬁle
at 17.weeks shows an increased capacity of fat catabolism,
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Figure 4 qRT-PCR veriﬁcation. Comparison of the log2FC data for
the two sampling points between Microarray and qRT-PCR measured
samples. qRT-PCR data was normalized to the expression of the
housekeeping gene EF1α. Pearson correlation; r = 0.8314, p = 0.0008.
The dotted line indicates the linear regression line.
glycolysis and activity of the TCA cycle as well as cardiac
contractility and cardiac hypertrophy. Overall, the results
suggest a scenario where cardiac ventricles of TTA pre-fed
ﬁsh are able to generate more energy via a TCA-cycle that
is fueled by metabolites from fat catabolism and glycoly-
sis. TTA functions as a ligand for all three PPAR subtypes
[3,4], which have crucial functions in the transcriptional
regulation of cardiac metabolism. In mice the transcrip-
tional eﬀects of TTA in the heart have been shown to
be mediated almost exclusively via PPARα [38]. Gain-
of-function and loss-of-function mutations have shown
that PPARα is a crucial transcription factor in the cardiac
metabolism, regulating mainly cardiac fatty acid uptake
and oxidation [10,11]. Furthermore, activation of PPARα
has been demonstrated to shift cardiac energy utiliza-
tion away from glucose and towards fatty acid oxidation,
actually mimicking the cardiac phenotype observed in
diabetic hearts [11]. Interestingly the cardiac phenotype
of PPARβ diﬀers from that of PPARα, indicating that
both transcription factors regulate, at least partly, diﬀer-
ent subsets of genes in the heart. PPARβ loss-of-function
hearts suﬀer from myocardial lipid accumulation and
cardiomyopathy [13]. Gain-of-function mutations on the
other hand clearly show that PPARβ positively regulates
cardiac glucose utilization [12], and also stimulates car-
diac growth [39]. Thus, the signiﬁcantly higher cardiac
transcription of PPARα and the elevated mean transcrip-
tion of PPARβ/ in concert with the activation of their
down-stream pathways, fat catabolism and the glycolysis
pathway suggest that cardiac eﬀects of TTA in Atlantic
salmon are mediated by both PPARα and PPARβ . Intrigu-
ingly, over-expression of a constitutively active form of
PPARβ in murine skeletal muscle has been reported to
mimic training-based muscle adaptation [40]. Hence, it
has been speculated, in accordance with the results from
PPARβ over-expression in mice [12], that PPARβ causes
“physiological” cardiac hypertrophy [39].
Between the 8.weeks and 17.weeks sampling points,
the hearts grew by a considerable portion in abso-
lute and relative terms. The gene expression pro-
ﬁle in hearts of TTA fed ﬁsh at 17.weeks suggests
that the cardiac growth of TTA fed ﬁsh is shifted
towards “physiological” hypertrophy, which may translate
to an increased cardiac output. This notion is sup-
ported by the expression proﬁle found for the cate-
gory “cardiac performance” at 17.weeks, unanimously
pointing to an increased cardiac contractility and also
showing up-regulation of crucial cardiac transcription
factors. In particular the higher transcription of the car-
diac transcription factors Nkx2.5 and Mef2C can be
regarded as markers for cardiac hypertrophy/growth.
It has been demonstrated in mice that over-expression
of Mef2C is suﬃcient to induce cardiac hypertro-
phy [41]. Furthermore, both Mef2C and Nkx2.5 have
been shown, in vitro, to be regulated by PPARα in
cardiomyocytes [42].
It should also be noted that although we did not ﬁnd sig-
niﬁcant diﬀerences in relative heart weight in this study,
in other studies we found that TTA signiﬁcantly increases
heart size in Atlantic salmon [8,9], and that the eﬀect
seems to be correlated to the dose of TTA (Rørvik, unpub-
lished data). Thus, it is tempting to speculate that the
increase in relative heart weight may be related to the
cardiac transcriptional changes induced by TTA. A “car-
diac exercise” stimulating eﬀect is of high relevance for
salmonid aquaculture. Atlantic salmon, having a circula-
tory system that is naturally adapted to long migration
routes and high activity, show alteration in cardiac mor-
phology and a reduced relative heart weight in captivity
[43]. In addition, circulatory failure has been identiﬁed as
an important cause of mortality in salmon farming [44].
Thus, using TTA may be one way to support the cardiac
performance of ﬁsh in captivity.
The highest tissue concentrations of TTA in Atlantic
salmon, as well as in mice, can be found in the heart
[1,45]. In accordance, the heart was also the tissue where
the strongest transcriptional response of PPARα was
detected. The main transcriptional eﬀects were found
nine weeks after the TTA feeding stopped and where
our data suggested that the cardiac tissue levels of TTA
were neglectable. However, we have no information about
the course of gene expression between both sampling
points, thus it might very well be that the eﬀects of
sampling at 17.weeks are the remains of earlier, stronger
transcriptional eﬀects. It is remarkable that a similar,
delayed response in expression of lipidmetabolism related
genes to TTA has been observed in our previous Atlantic
Grammes et al. BMCGenomics 2012, 13:180 Page 8 of 13
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Figure 5 Gene expression. A: Expression of PPARα, β and γ in Atlantic salmon fed TTA or a control diet. The diﬀerent tissues liver, heart, muscle
and gut were sampled at two sampling points (8.weeks and 17.weeks). B: Cardiac expression of Gata4,Myocyte-specific enhancer factor 2C (Mef2C)
and Nkx2.5 in Atlantic salmon fed TTA or a control diet. Gene expression was normalized to the expression of the housekeeping gene EF1α. The
p-values for the eﬀects of Diet, Time and Interaction from the two way ANOVA are displayed in the upper right corner. Data are presented as means
± SEM, n = 6.
salmon studies [8,9], indicating a common underlying
mechanism. It is possible that the delay in transcrip-
tional response is caused by a common, yet unknown,
mechanism.
Conclusions
In conclusion, based on results from microarray analysis,
this study demonstrates that TTA increases cardiac fatty
acid oxidation and glycolysis as well as contractility and
cardiac hypertrophy in Atlantic salmon. The gene expres-
sion proﬁles further favor a scenario of “physiological”
hypertrophy in response to TTA. This increased cardiac
eﬃciency may oﬀer signiﬁcant beneﬁts in situations with
increased oxygen demand.
Methods
Feeding trial
The experiment was conducted at Noﬁma Marin sea-
water research station, Averøy, western Norway. Atlantic
salmon used in this experiment were hatched at Noﬁma
Marin research station (Sunndaløra, Norway) one year
earlier (S1/1+ Salmon). The experiment started with the
seawater transfer of the ﬁsh on the 15th of May 2007 and
lasted until the 27th of September 2007. A randomized
block design with triplicate seawater net-pens and 400
ﬁsh per pen (pen = 125 m3) was used for the experiment.
Control and TTA diets (0.25% (w/w) TTA (Thia Medica,
Norway)) were produced by Biomar (Biomar AS, Myre,
Norway). Both TTA and control diets were fed to the ﬁsh
Grammes et al. BMC Genomics 2012, 13:180 Page 9 of 13
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until the 16th of July 2007, from this point until the end
of the experiment only the control diet was fed to the ﬁsh.
Low levels of TTA (0.25%) and a short feeding period were
chosen in order to avoid negative TTA eﬀects (mortal-
ity, altered kidney morphology [1,46]). TTA was fed for
the ﬁrst eight weeks after sea transfer, a period where the
physiology of the salmon alters due to changing from a
fresh to a saltwater environment; and we speculated that
an increased capacity for energy utilization may be bene-
ﬁcial. Fish were sampled from the cages to represent the
average ﬁsh weight for the cage. Sampling was done on
the following dates: 16-18th of July 2007 (sampling point:
8.weeks, end of the TTA feeding period) and 25-27th of
September 2007 (sampling point: 17.weeks). For each sam-
pling point, ﬁsh were sampled for: heart ventricle, liver,
muscle and gut (pyloric caeca). The tissue samples were
snap frozen in liquid nitrogen and stored at -80°C.
Fat analysis
Fat content in the muscle (Norwegian quality cut–NQC,
Norwegian standard procedure - NS 9401 1994) was mea-
sured in pooled samples (10 ﬁsh) from each net pen as
described in [47]. TTA was measured within the total car-
diac lipids. For the analysis 10 ventricles from Atlantic
salmon out of the same net pen were pooled. Total heart
lipids were extracted with chloroform-methanol [48] and
fatty acid methyl esters (FAME) were obtained by heat-
ing of lipids with methanol at 90°C/1 hour, where H2SO4
was used as a catalyst [49]. After extraction into an
organic solvent, the FAME were analyzed by gas-liquid
chromatography. A gas chromatograph GC 8000 TOP
(Finnigan, USA) was equipped with a programmed tem-
perature vaporization (PTV) injector, ﬂame-ionization
detector (FID), AS 800 autosampler and a fused silica
capillary column coated with dimethylpolysiloxane sta-
tionary phase, DB1-ms (J &W Scientiﬁc, USA). Hydrogen
was used as a carrier gas. Column temperature was pro-
grammed from 110 to 310°C with a gradient 2.5°C/min.
The GC signal was acquired using Chromeleon soft-
ware (Dionex, USA). Peaks were identiﬁed by means of
known FA standards (Larodan Fine Chemicals, Sweden
and Sigma-Aldrich, USA) and by means of mass spectra,
obtained by GC/MS analysis (GCQ, Finnigan, USA) on
the same column. An internal standard (C21:0) was used
for quantitation after calibration with known mixtures of
FA standards.
RNA extraction
Two individual samples from each one of the 3 net-pens
were samples for heart ventricle, liver, muscle and gut. The
samples were randomly chosen (n = 6 per dietary group
and sampling point) and homogenized using a rotor tis-
sue lyser (Precellys 24, Bertin technologies, France). Total
RNA was extracted and puriﬁed using column puriﬁca-
tion (96 universal Tissue Kit, Qiagen, Hilden, Germany)
according to the manufacturer’s instructions. Traces of
genomic DNA in the samples were eliminated by on-
column-DNase digestion (Qiagen). RNA concentrations
were measured for all samples using a NanoDrop 1000
Spectrophotometer (Thermo Fisher Scientiﬁc, Wilming-
ton, USA). RNA quality for samples later used in the
microarray was determined using a Agilent 2100 Bio-
analyzer (RNA 6000 NanoLabChip, Agilent, Waldborn,
Germany).
Microarray hybridization
A customized oligo (60-mer) Atlantic salmon microarray
in the 4x44K format (Agilent, [18]) was used to detect
diﬀerential gene expression between samples from the
heart ventricles of control and 0.25% TTA fed ﬁsh for
the 8.weeks and 17.weeks sampling points. The array
contained 21012 diﬀerent probes spotted in duplicates.
RNA samples from individual ﬁsh were hybridized to
the microarray. 24 individual microarrays were performed
using 12 ﬁsh (6 control and 6 TTA ﬁsh) at the 8 week
sampling point, and similarly at the 17 week sampling
point. All RNA samples used in the hybridization had RIN
values ranging from 9.5 to 10. 500ng RNA were ampliﬁed
and labeled with Cy3 using the Quick Amp Labeling Kit
(One Color-Agilent). After puriﬁcation the cRNA was
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quantiﬁed using NanoDrop. Subsequently 1.65μg Cy-dye-
labeled cRNA was fragmented (mean size, approximately
50-100 nucleotides) with fragmentation buﬀer (Agilent
Technologies) at 60°C for 30 min; cRNA was subsequently
hybridized to the microarray at 65°C for 17 h. All steps
were conducted according to the Agilent protocol (One-
Color Quick Amp Labeling, Version 5.7). The microarray
chips were scanned using a Agilent Microarray Scanner
(G2565CA) and analysis of the microarray images was
done in Agilent’s Feature Extraction Software (Version
10.5.1.1) using the one-color (GE1 105 Dec08) protocol.
Microarray analysis
Normalization and analysis of the data was performed in
R/Bioconductor [50,51] using the “limma” package [20].
The background corrected ﬂuorescence signals (gPro-
cessedSignal) were obtained from Feature Extraction
(Agilent). Spots were ﬁltered according to the follow-
ing criteria provided by Feature Extraction: gIsFound,
gIsPosAndSignif and gIsWellAboveBG (a description of
the parameters can be found in the Feature Extrac-
tion Software Reference Guide). The mean signal of the
duplicated probes was calculated and all control spots
together with probe sets showing more than three miss-
ing values were removed from the dataset. The data
was subsequently normalized using quantile normaliza-
tion in order to adjust the scale of intensities across arrays
[52]. After normalization the signals were log2 trans-
formed. The normalized/ﬁltered dataset then contained
13166 probe sets (63% of the total). The raw and normal-
ized data is publicly available at NCBI’s GEO repository
(http://www.ncbi.nlm.nih.gov/geo/, AccNr: GSE25305).
Diﬀerential expression of probe sets was assessed by
ﬁtting a linear model, including the eﬀects of feeding
(2 levels: Control and TTA) and the eﬀects of sam-
pling point (2 levels: 8.weeks and 17.weeks) and their
interaction. The speciﬁc comparisons: TTA vs. Con-
trol at sampling point 8.weeks and TTA vs. Control at
sampling point 17.weeks were made by extracting the
appropriate contrasts from the linear model. For each
contrast moderated t-statistics were calculated using an
empirical Bayes method [53]. Probes without annota-
tion were removed from the dataset before controlling
the false discovery rate [54] simultaneously across probe
sets and contrasts (method: “ global” in the limma func-
tion “decideTests”). Probe sets with a q-value ≤ 0.05
and a log2FC ≥ 0.5 were declared DE for the corre-
sponding contrast. A comprehensive list of all DE probes
for each contrast can be found in Additional ﬁle 5:
Table S3.
Probe annotation and GOs were retrieved using the
top Blast function implemented in Blast2GO [55]. Full
length probe sequences were blasted against protein
sequences from the Swissprot database in a BlastX search.
The E-value cut oﬀ was set to 10−6. Hypergeomet-
ric testing for over-representation of GO terms from
the category biological process [25] among the genes
DE for the contrast TTA vs. Control at the 17.weeks
sampling point was conducted using the GOstats pack-
age [26]. Before testing, probes matching to the same
gene were collapsed to the probe showing the largest
variance.
Correspondence analysis was conducted using the R
package “made4” [56]. Probe sets with missing values
Table 3 qRT-PCR primer sequences
Gene Accession no. Forward primer (3’ - 5’) Reverse primer (5’ - 3’)
mt D Loop B (gDNA) NC001960 CCCCTGAAAGCCGAATGTAA CGACCTTGTTAGACTTCTTTGCTTG
MyoD2 (gDNA) AJ557150 CAGAGCCAGGATTACACTCGTTACA GCATGTCGCTGGTGTTGAAG
PPARα DQ294237 TCCTGGTGGCCTACGGATC CGTTGAATTTCATGGCGAACT
PPARβ AJ416953 GAGACGGTCAGGGAGCTCAC CCAGCAACCCGTCCTTGTT
PPARγ AJ416951 CATTGTCAGCCTGTCCAGAC TTGCAGCCCTCACAGACATG
EF1α AF321836 CACCACCGGCCATCTGATCTACAA TCAGCAGCCTCCTTCTCGAACTTC
MYH6 DW559270 CAGGTCCTCTATGTGCTGGTGTG TCCTCATTGTAGTTGCTGTCCTCAC
ANGL4 GRASP209147493 CCGTATGGGGGATGATGCTAA GGTAGTATGCTGACGACTGACACCT
GTR1 S30269700 GCCATGGATGTCCTACGTGA CTCCGCTACATACGGGAAGG
CPT1A S31823509 TCCCACATCATCCCCTTCAACT TGTCCCTGAAGTGAGCCAGCT
ACADS S31978689 CTGGGGAAGAAGGAGGACAAG TCTAGAGCAGCCTGAGCAATACC
NKX2.5 DW550500 CCCAGTACGTCCACACCCTT GGAGGTCGGTAAGGCACAGT
Mef2C GU252207 CACCGTAACTCGCCTGGTCT GCTTGCGGTTGCTGTTCATA
GATA4 HM475152 TCTCCATTCGACAGCTCCGT CATCGCTCCACAGTTCACACA
Osx FJ195614 ATTACTGAGGAGGAGCCCATCATT CCTCATCCACCTCACACACCTT
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were removed from the dataset prior to correspondence
analysis.
Quantitative RT-PCR
Single strand cDNA was synthesized from 500ng of
total RNA using oligo dT primers and the Taq Man
reverse transcription Kit (Applied Biosystems, CA, USA).
qRT-PCR was performed on a Light-Cycler 480 (Roche,
Switzerland). For the PCR reaction, 2x SYBR green I mas-
ter Mix (Roche), 0.41nM of each primer and the cDNA
template were mixed in a total reaction volume of 10μl.
Primer sequences are listed in Table 3. A three step PCR
protocol with 45 cycles (15s 95°C, 15s 60°C, 15s 72°C)
was used. To verify speciﬁc ampliﬁcation, a melting curve
analysis step was done at the end of the program. In
order to verify the results obtained through the microar-
ray experiment, the same 24 samples used in the array
were used in a qRT-PCR approach. Six genes were then
randomly picked and samples were analyzed in duplicates.
The expression level was calculated using the standard
curve method (Applied Biosystems User Bulletin 2). The
standard curve was produced from a serial dilution of a
pool consisting of all cDNA samples. The expression levels
were standardized to the expression of the housekeeping
gene elongation factor 1α (EF1α, [57]).
mt/nDNA ratio
Genomic DNA was isolated from tissue samples from
the same individuals as the ones used for the total RNA
extraction (totally 96 samples, n = 6). DNA was isolated
using DNAeasy kit (Qiagen) according to the manual. The
DNA quality for all samples was checked on a 1% agarose
gel and concentration was measured using a NanoDrop
Spectrophotometer. The MyoD gene (intron-exon span-
ning primers) and the mitochondrial D-loop were ampli-
ﬁed by qRT-PCR. For the PCR reaction 1x SYBR green
I master Mix (Roche), 0.41nM of each primer and the
6.4ng DNA template were mixed in a reaction volume
of 10μl. PCR ampliﬁcation was conducted as described
above. All reactions were run in duplicates. Absolute con-
centrations for mt- and nDNA samples were obtained
using the standard curvemethod. The ratio was calculated
by dividing the absolute mtDNA by the absolute nDNA
concentration.
Statistical analysis
All data are presented as means ± SEMwith an n value as
stated. The eﬀect of dietary treatment on the production
parameters and qRT-PCR were analyzed by 2-way anal-
ysis of variance (ANOVA), using dietary treatment and
sampling point as ﬁxed factors and block as a random fac-
tor. TTA eﬀects on gene expression and mt/nDNA ratio
were calculated using EF1α standardized expression val-
ues in a 2-way ANOVA with dietary treatment and time
as ﬁxed factors. Unless otherwise stated the statistical unit
is the individual ﬁsh. All analyses were conducted using
R [50], plots were produced using the R package ggplot
[58] and the heatmaps were produced with the R package
lattice/latticeExtra [59].
Additional ﬁles
Additional ﬁle 1: Table S1. TTA measurements in the cardiac ventricles.
Additional ﬁle 2: Figure S1. Overlap matrix of the genes from the 36 GO
terms that were signiﬁcantly over represented in TTA fed Atlantic salmon at
sampling point 17.weeks. Rows and columns are hierarchical clustered
(indicated by the dendrogram) based on euclidean distance. Overlap is
indicated by red color.
Additional ﬁle 3: Table S2. Full list of DE genes associated to
over-represented GO Biological processes terms at sampling point
17.weeks.
Additional ﬁle 4: Figure S2. KEGG Pathway diagram. Seven genes from
the category TCA (Table 2) could be annotated to a KEGG Ontology (KO)
using the program KAAS [60]. These 7 genes were highlighted (yellow/red)
in the KEGG reference pathway: TCA-cycle (ko:00020). The genes were
annotated to the following enzymes: Citrate synthase [EC:2.3.3.1] - 1 gene;
Isocitrate dehydrogenase [EC:1.1.1.42] - 1 gene; Isocitrate dehydrogenase
(NAD+) [EC:1.1.1.41] - 3 genes; Succinate dehydrogenase (ubiquinone)
ﬂavoprotein subunit [EC:1.3.5.1] - 1gene; and membrane anchor unit
[EC:1.3.5.1] -1 gene.
Additional ﬁle 5: Table S3. Full list of the DE genes after collapsing.
Column 1: Probe ID; Column 2: log2FCs of the contrast TTA vs. Control for
sampling point 8.weeks; Column 3: log2FCs of the contrast TTA vs. Control
for sampling point 17.weeks; Column 4-6: Gene annotation: Gene name,
gene symbol and e-value. Column 7-8: Signiﬁcance of the corresponding
gene for the corresponding contrast. Column 9: Joint between GeneID
and Symbol, as used in the heatmaps.
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